

Cover Story
ClinicalNews Analysis
By Jacquelyn Cobb and Paul Goldberg
The American Cancer Society’s 2026 annual statistics report trumpets a symbolic milestone for oncology—for the first time, the five-year relative survival rate for all cancers combined has reached 70% for people diagnosed between 2015 and 2021 in the U.S.
Cancer Policy
In Brief
Clinical Roundup


Drugs & Targets


Trending Stories
- Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pam Bondi diagnosed with thyroid cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Wafik El-Deiry steps down as director of Brown’s Legorreta Cancer Center
















